Wolverine Trading, LLC Biogen Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $1.08 Million - $1.35 Million	5,700 Added 31.15%	24,000 $4.65 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $57,156 - $71,016	-300 Reduced 1.61%	18,300 $4.24 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $678,464 - $856,671	-3,200 Reduced 14.68%	18,600 $4.01 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $22,259 - $26,794	100 Added 0.46%	21,800 $5.64 Million
Q3 2023 Nov 15, 2023	SELL	$253.3 - $285.89 $3.52 Million - $3.97 Million	-13,900 Reduced 39.04%	21,700 $5.58 Million
Q2 2023 Aug 23, 2023	BUY	$275.25 - $318.06 $1.27 Million - $1.46 Million	4,600 Added 14.84%	35,600 $10.1 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $6.95 Million - $7.92 Million	-27,100 Reduced 46.64%	31,000 $8.53 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $14.1 Million - $17.2 Million	-56,000 Reduced 49.08%	58,100 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $7.88 Million - $10.9 Million	40,500 Added 55.03%	114,100 $30.2 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $1.67 Million - $1.98 Million	8,900 Added 13.76%	73,600 $15.1 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $988,227 - $1.25 Million	-5,100 Reduced 7.31%	64,700 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.25 Million - $1.61 Million	5,600 Added 8.72%	69,800 $16.8 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $17.7 Million - $23.1 Million	-62,500 Reduced 49.33%	64,200 $18.3 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $17.5 Million - $28 Million	67,500 Added 114.02%	126,700 $43.8 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $4.69 Million - $5.49 Million	-19,300 Reduced 24.59%	59,200 $16.3 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $3.24 Million - $4.87 Million	13,700 Added 21.14%	78,500 $19.1 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $3.07 Million - $3.55 Million	-11,600 Reduced 15.18%	64,800 $18.3 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $2.51 Million - $3.32 Million	9,700 Added 14.54%	76,400 $19.9 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $16.7 Million - $21.2 Million	-62,300 Reduced 48.29%	66,700 $21.1 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $4.2 Million - $5.81 Million	19,100 Added 17.38%	129,000 $38.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $10.9 Million - $12.2 Million	-49,900 Reduced 31.23%	109,900 $25.3 Million
Q2 2019 Aug 20, 2019	SELL	$219.29 - $241.72 $16.9 Million - $18.6 Million	-77,000 Reduced 32.52%	159,800 $37.4 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $17.4 Million - $27.2 Million	80,200 Added 51.21%	236,800 $56 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.23 Million - $1.55 Million	-4,400 Reduced 2.73%	156,600 $46 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $15.1 Million - $19.8 Million	51,600 Added 47.17%	161,000 $56.9 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $9.88 Million - $14 Million	-38,000 Reduced 25.78%	109,400 $30 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $2.06 Million - $2.31 Million	-6,700 Reduced 4.35%	147,400 $47 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $43.3 Million - $50.8 Million	154,100	154,100 $48.3 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account